Lucid Tala vs Signia Pure C&G IX

The Lucid Tala is a premium-priced OTC hearing aid at $1,300, earning an A grade with a SoundScore of 4.6/5 in our lab testing. Ranking #4 among 65 OTC hearing aids tested, it places in the top 5% of its category and has received HearAdvisor's Expert's Choice Award in both 2023 and 2024. Speech performance is a clear strength. Speech in Quiet scores an excellent 4.6/5, measuring 1.85 points above the category average. Speech in Noise reaches a solid 3.0/5, which is 1.56 points above the OTC average of 1.48—a meaningful advantage for conversations in challenging environments. Music streaming also performs well at 3.0/5, exceeding the category average by 1.08 points. The primary weakness is feedback handling, which scores a low 1.7/5 in our tuned testing—2.84 points below the category average of 4.54. This suggests users may experience more whistling or feedback artifacts than typical OTC devices. Own-voice comfort is mixed at 2.6/5, sitting just above the category average but not standing out in absolute terms. The Lucid Tala is best suited for users who prioritize speech clarity and are willing to pay premium OTC pricing for strong intelligibility performance. Those highly sensitive to feedback may want to consider alternatives. At this price point, comparable options include the Audicus Omni 2, though budget-conscious shoppers might explore lower-priced devices like the Elehear Beyond or Yeasound RIC700, which also deliver strong sound performance in our testing.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.